Plasmabiotech is a biotech company with an innovative vision and dedication to developing new products in the field of regenerative medicine. We are the developer, manufacturer and the distributor of patented SPB PRP products for autologous blood plasma therapy.
The company is leading a paradigm shift in autologous plasma therapies. Plasmobiotech is headquartered at the Schwerzenbach ZH, near Zurich.
Consists of an experienced and well-balanced team with complementary skill-sets. The Chairman and Chief Executive Officer is Ihsan Yalcin, a Swedish national, who has extensive experience in business strategy- development and global management. He holds a Bachelor Degree in Economics and a Bachelor of Science degree in International Business Management from Karlstad University.
People are at the heart of everything we do. We strive towards making a difference in the field of regenerative medicine for the benefits of the patients. With expertise, care and persistence, we aim to be a leading provider of autologous plasma therapy products. We focus on providing a comprehensive, future-oriented service, to provide a foundation for long-term business relations.
Quality is not just a statement, but part of our daily commitment. Our PRP Product is certificated in accordance EN ISO 13485, Class IIa a medical device in line with the Directive 93/42/EEC and subsequent(which means that the plasma obtained using them can be injected immediately after centrifugation into the body) and manufactured according to GMP standards.